← Browse by Condition
Medical Condition
heart transplant failure
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 3, Phase 1
ClinicalMetric tracks all active clinical trials for heart transplant failure sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1 1
Phase 2 1
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
NCT04180085 Phase 2
Recruiting
Pilot Study: Interest of Belatacept as a Non-nephrotoxic Immunosuppressive Treatment in Cardiac Transplant Patients at Risk of Chronic Renal Failure (BELACOEUR)
Enrollment
25 pts
Location
France
Sponsor
Nantes University Hospital
NCT05321706 Phase 3
Recruiting
DAPAgliflozin for Renal Protection in Heart Transplant Recipients
Enrollment
430 pts
Location
Netherlands, Norway,...
Sponsor
Oslo University Hospital
NCT06428097 Phase 1
Recruiting
Levothyroxine Supplementation for Heart Transplant Recipients
Enrollment
97 pts
Location
United States
Sponsor
University of California, San ...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology